Results 321 to 330 of about 3,264,535 (355)

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

Solid phase synthesis of a trypsin inhibitor isolated from the Cucurbitaceae Ecballium elaterium.

International journal of peptide & protein research, 2009
D. Le-Nguyen, D. Nalis, B. Castro
semanticscholar   +1 more source

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed?

Thrombosis and Haemostasis, 2009
H. Spronk, A. Dielis, M. Panova-Noeva, R. Oerle, J. Govers-Riemslag, K. Hamulyák, A. Falanga, H. Cate   +7 more
semanticscholar   +1 more source

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Soybean Trypsin Inhibitor

2007
S.J. Enna, David B. Bylund
openaire   +1 more source

The normal modes of a protein: Native bovine pancreatic trypsin inhibitor

, 2009
M. Levitt, C. Sander, P. Stern
semanticscholar   +1 more source

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

Corn Trypsin Inhibitor

2007
S.J. Enna, David B. Bylund
openaire   +1 more source